IL164400A0 - Deruvatuves if n-Äphenyl(piperidin-2-yl)methylÜbenzamide, the preparation method thereof and application of same in therapeutics - Google Patents

Deruvatuves if n-Äphenyl(piperidin-2-yl)methylÜbenzamide, the preparation method thereof and application of same in therapeutics

Info

Publication number: IL164400A0
Authority: IL; Israel
Prior art keywords: äphenyl; methylübenzamide; deruvatuves; piperidin; therapeutics
Prior art date: 2002-04-19

Application number

IL16440003A

Other languages

English (en)

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-19

Filing date

2003-04-17

Publication date

2005-12-18

2003-04-17 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2005-12-18 Publication of IL164400A0 publication Critical patent/IL164400A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Anesthesiology (AREA)
Addiction (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Hydrogenated Pyridines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)

IL16440003A 2002-04-19 2003-04-17 Deruvatuves if n-Äphenyl(piperidin-2-yl)methylÜbenzamide, the preparation method thereof and application of same in therapeutics IL164400A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0204916A FR2838739B1 (fr)	2002-04-19	2002-04-19	Derives de n-[phenyl(piperidin-2-yl)methyl)benzamide, leur preparation et leur application en therapeutique
PCT/FR2003/001232 WO2003089411A1 (fr)	2002-04-19	2003-04-17	Derives de n-[phenyl(piperidin-2-yl)methyl] benzamide, leur preparation et leur application en therapeutique

Publications (1)

Publication Number	Publication Date
IL164400A0 true IL164400A0 (en)	2005-12-18

Family

ID=28686193

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL16440003A IL164400A0 (en)	2002-04-19	2003-04-17	Deruvatuves if n-Äphenyl(piperidin-2-yl)methylÜbenzamide, the preparation method thereof and application of same in therapeutics
IL164400A IL164400A (en)	2002-04-19	2004-10-04	Derivatives of n - [phenyl(piperidin-2 - yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL164400A IL164400A (en)	2002-04-19	2004-10-04	Derivatives of n - [phenyl(piperidin-2 - yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics

Country Status (35)

Country	Link
US (2)	US7326722B2 (no)
EP (1)	EP1499589B1 (no)
JP (1)	JP4597532B2 (no)
KR (2)	KR20040103973A (no)
CN (1)	CN100482646C (no)
AR (1)	AR039413A1 (no)
AT (1)	ATE361279T1 (no)
AU (1)	AU2003262420B2 (no)
BR (1)	BR0309397A (no)
CA (1)	CA2481461C (no)
CO (1)	CO5631432A2 (no)
CY (1)	CY1108025T1 (no)
DE (1)	DE60313602T2 (no)
DK (1)	DK1499589T3 (no)
EA (1)	EA007225B1 (no)
EC (1)	ECSP045369A (no)
ES (1)	ES2286444T3 (no)
FR (1)	FR2838739B1 (no)
HR (1)	HRP20040977B1 (no)
IL (2)	IL164400A0 (no)
IS (1)	IS2540B (no)
MA (1)	MA27192A1 (no)
ME (1)	MEP25608A (no)
MX (1)	MXPA04010326A (no)
NO (1)	NO329065B1 (no)
NZ (1)	NZ536015A (no)
PL (1)	PL373195A1 (no)
PT (1)	PT1499589E (no)
RS (1)	RS51888B (no)
SI (1)	SI1499589T1 (no)
TN (1)	TNSN04208A1 (no)
TW (1)	TWI306402B (no)
UA (1)	UA78025C2 (no)
WO (1)	WO2003089411A1 (no)
ZA (1)	ZA200408154B (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2842804B1 (fr)	2002-07-29	2004-09-03	Sanofi Synthelabo	Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
FR2861073B1 (fr) *	2003-10-17	2006-01-06	Sanofi Synthelabo	Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
FR2861071B1 (fr) *	2003-10-17	2006-01-06	Sanofi Synthelabo	Derives de n-[phenyl(alkylpiperidin-2-yl) methyl]benzamide, leur prepartation et leur application en therapeutique
FR2861074B1 (fr)	2003-10-17	2006-04-07	Sanofi Synthelabo	Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
FR2861070B1 (fr) *	2003-10-17	2006-01-06	Sanofi Synthelabo	Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide et n-[(azepan-2-yl)phenylmethyl]benzamide, leur preparation et leur application en therapeutique
US7202269B2 (en)	2003-10-30	2007-04-10	Janssen Pharmaceutica N.V.	GlyT2 modulators
US20050209317A1 (en) *	2004-03-22	2005-09-22	Apkarian A V	Method and compositions for treatment of chronic neuropathic pain
EP1869019B1 (en)	2005-04-08	2014-08-27	Pfizer Products Inc.	Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors
JP2009179562A (ja) *	2006-08-11	2009-08-13	Taisho Pharmaceutical Co Ltd	グリシントランスポーター阻害剤
FR2917735B1 (fr) *	2007-06-21	2009-09-04	Sanofi Aventis Sa	Nouveaux indazoles substitutes, leur preparation et leur utilisation en therapeutique
TW200911808A (en) *	2007-07-23	2009-03-16	Astrazeneca Ab	Novel compounds
CA2691450A1 (en) *	2007-08-22	2009-02-26	Abbott Gmbh & Co. Kg	4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy
ES2397764T3 (es)	2008-04-01	2013-03-11	Abbott Gmbh & Co. Kg	Tetrahidroisoquinolinas, composiciones farmacéuticas que las contienen, y su uso en terapia
AR075182A1 (es) *	2009-01-28	2011-03-16	Astrazeneca Ab	Compuestos 2-aza-biciclo (2.2.2) octano y sus usos
AR075442A1 (es)	2009-02-16	2011-03-30	Abbott Gmbh & Co Kg	Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
TW201038569A (en)	2009-02-16	2010-11-01	Abbott Gmbh & Co Kg	Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
JP5618047B2 (ja) *	2010-01-29	2014-11-05	国立大学法人千葉大学	ポジトロン断層撮影法およびポジトロン放出化合物
US8846743B2 (en)	2010-08-13	2014-09-30	Abbott Laboratories	Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9051280B2 (en)	2010-08-13	2015-06-09	AbbVie Deutschland GmbH & Co. KG	Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US8883839B2 (en)	2010-08-13	2014-11-11	Abbott Laboratories	Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9045459B2 (en)	2010-08-13	2015-06-02	AbbVie Deutschland GmbH & Co. KG	Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8877794B2 (en)	2010-08-13	2014-11-04	Abbott Laboratories	Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9309200B2 (en)	2011-05-12	2016-04-12	AbbVie Deutschland GmbH & Co. KG	Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8778941B2 (en)	2011-06-24	2014-07-15	Amgen Inc.	TRPM8 antagonists and their use in treatments
EA201490152A1 (ru)	2011-06-24	2014-05-30	Эмджен Инк.	Антагонисты trpm8 и их применение при лечении
CN103889968A (zh)	2011-08-05	2014-06-25	艾伯维德国有限责任两合公司	氨基苯并二氢吡喃、氨基苯并二氢噻喃及氨基-1,2,3,4-四氢喹啉衍生物，包含这些化合物的药用组合物，及其在治疗中的用途
MX2014006004A (es)	2011-11-18	2015-04-16	Abbvie Deutschland	Derivados de aminobenzociclohepteno, aminotetralina, aminoindano y fenalcilamina n-sustituidas, composiciones farmaceuticas que los contienen, y su uso en terapia.
FR2983197B1 (fr) *	2011-11-29	2014-07-25	Assist Publ Hopitaux De Paris	Utilisation de phacetoperane pour traiter un trouble deficit de l'attention hyperactivite
US9365512B2 (en)	2012-02-13	2016-06-14	AbbVie Deutschland GmbH & Co. KG	Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
US8952009B2 (en)	2012-08-06	2015-02-10	Amgen Inc.	Chroman derivatives as TRPM8 inhibitors
US9656955B2 (en)	2013-03-15	2017-05-23	Abbvie Inc.	Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9650334B2 (en)	2013-03-15	2017-05-16	Abbvie Inc.	Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
MX2016004936A (es)	2013-10-17	2016-12-20	Abbvie Deutschland	Derivados de aminocromano, aminotiocromano y amino-1,2,3,4-tetrahi droquinilina, composiciones farmaceuticas que los contienen, y su uso en terapia.
JP2016533375A (ja)	2013-10-17	2016-10-27	アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー	アミノテトラリン誘導体およびアミノインダン誘導体、これらを含有する医薬組成物、および治療におけるこれらの使用
US9550754B2 (en)	2014-09-11	2017-01-24	AbbVie Deutschland GmbH & Co. KG	4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy
US20170143681A1 (en)	2015-11-02	2017-05-25	Apkarian Technologies Llc	Methods and compositions for treating pain
FR3045044B1 (fr) *	2015-12-11	2019-04-19	Liphatech	Composition et appat rodonticide comprenant du flocoumafene, procede de lutte contre des rongeurs cibles nuisibles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5254569A (en) *	1991-01-14	1993-10-19	The Du Pont Merck Pharmaceutical Company	(Amidomethyl)nitrogen heterocyclic analgesics
JP3026845B2 (ja) *	1991-02-20	2000-03-27	日清製粉株式会社	ピペリジン誘導体
US5524569A (en)	1995-03-20	1996-06-11	Rich; William A.	Anchor cover
PL342818A1 (en) *	1998-03-06	2001-07-02	Janssen Pharmaceutica Nv	Glycin transport inhibitors
WO2001081308A2 (en) *	2000-04-20	2001-11-01	Nps Allelix Corp.	Aminopiperidines for use as glyt-1 inhibitors

2002
- 2002-04-19 FR FR0204916A patent/FR2838739B1/fr not_active Expired - Fee Related
2003
- 2003-04-15 AR ARP030101310A patent/AR039413A1/es unknown
- 2003-04-17 DE DE60313602T patent/DE60313602T2/de not_active Expired - Lifetime
- 2003-04-17 AT AT03740634T patent/ATE361279T1/de active
- 2003-04-17 KR KR10-2004-7016718A patent/KR20040103973A/ko not_active Application Discontinuation
- 2003-04-17 CA CA002481461A patent/CA2481461C/en not_active Expired - Fee Related
- 2003-04-17 SI SI200330893T patent/SI1499589T1/sl unknown
- 2003-04-17 NZ NZ536015A patent/NZ536015A/en not_active IP Right Cessation
- 2003-04-17 EA EA200401172A patent/EA007225B1/ru not_active IP Right Cessation
- 2003-04-17 IL IL16440003A patent/IL164400A0/xx unknown
- 2003-04-17 AU AU2003262420A patent/AU2003262420B2/en not_active Ceased
- 2003-04-17 UA UA20041008110A patent/UA78025C2/uk unknown
- 2003-04-17 KR KR1020087018794A patent/KR101019313B1/ko not_active IP Right Cessation
- 2003-04-17 PL PL03373195A patent/PL373195A1/xx not_active IP Right Cessation
- 2003-04-17 WO PCT/FR2003/001232 patent/WO2003089411A1/fr active IP Right Grant
- 2003-04-17 JP JP2003586132A patent/JP4597532B2/ja not_active Expired - Fee Related
- 2003-04-17 EP EP03740634A patent/EP1499589B1/fr not_active Expired - Lifetime
- 2003-04-17 ME MEP-256/08A patent/MEP25608A/xx unknown
- 2003-04-17 ES ES03740634T patent/ES2286444T3/es not_active Expired - Lifetime
- 2003-04-17 CN CNB038140063A patent/CN100482646C/zh not_active Expired - Fee Related
- 2003-04-17 RS YU91404A patent/RS51888B/en unknown
- 2003-04-17 US US10/511,886 patent/US7326722B2/en not_active Expired - Fee Related
- 2003-04-17 PT PT03740634T patent/PT1499589E/pt unknown
- 2003-04-17 DK DK03740634T patent/DK1499589T3/da active
- 2003-04-17 BR BR0309397-2A patent/BR0309397A/pt not_active IP Right Cessation
- 2003-04-17 MX MXPA04010326A patent/MXPA04010326A/es active IP Right Grant
- 2003-04-18 TW TW092109074A patent/TWI306402B/zh not_active IP Right Cessation
2004
- 2004-09-30 IS IS7479A patent/IS2540B/is unknown
- 2004-10-04 IL IL164400A patent/IL164400A/en not_active IP Right Cessation
- 2004-10-07 MA MA27892A patent/MA27192A1/fr unknown
- 2004-10-08 ZA ZA200408154A patent/ZA200408154B/en unknown
- 2004-10-14 CO CO04103284A patent/CO5631432A2/es not_active Application Discontinuation
- 2004-10-15 NO NO20044388A patent/NO329065B1/no not_active IP Right Cessation
- 2004-10-18 EC EC2004005369A patent/ECSP045369A/es unknown
- 2004-10-18 TN TNP2004000208A patent/TNSN04208A1/fr unknown
- 2004-10-18 HR HR20040977A patent/HRP20040977B1/xx not_active IP Right Cessation
2007
- 2007-04-03 US US11/695,912 patent/US20070197601A1/en not_active Abandoned
- 2007-07-24 CY CY20071100988T patent/CY1108025T1/el unknown

Also Published As

Publication number	Publication date
MA27192A1 (fr)	2005-01-03
CA2481461C (en)	2010-01-12
FR2838739B1 (fr)	2004-05-28
PL373195A1 (en)	2005-08-22
NO329065B1 (no)	2010-08-09
ZA200408154B (en)	2005-10-10
KR101019313B1 (ko)	2011-03-07
US7326722B2 (en)	2008-02-05
FR2838739A1 (fr)	2003-10-24
IS7479A (is)	2004-09-30
JP2005527593A (ja)	2005-09-15
CN100482646C (zh)	2009-04-29
HRP20040977B1 (en)	2008-04-30
TW200306830A (en)	2003-12-01
WO2003089411A1 (fr)	2003-10-30
BR0309397A (pt)	2005-03-01
US20070197601A1 (en)	2007-08-23
KR20040103973A (ko)	2004-12-09
DK1499589T3 (da)	2007-09-10
NO20044388L (no)	2005-01-19
CO5631432A2 (es)	2006-04-28
EP1499589B1 (fr)	2007-05-02
CA2481461A1 (en)	2003-10-30
DE60313602D1 (de)	2007-06-14
DE60313602T2 (de)	2008-01-10
RS91404A (en)	2007-02-05
AU2003262420B2 (en)	2009-02-19
MEP25608A (en)	2010-06-10
PT1499589E (pt)	2007-08-10
JP4597532B2 (ja)	2010-12-15
TWI306402B (en)	2009-02-21
ECSP045369A (es)	2005-03-10
EA200401172A1 (ru)	2005-04-28
AR039413A1 (es)	2005-02-16
ES2286444T3 (es)	2007-12-01
KR20080075236A (ko)	2008-08-14
TNSN04208A1 (fr)	2007-03-12
EP1499589A1 (fr)	2005-01-26
CY1108025T1 (el)	2013-09-04
IL164400A (en)	2010-11-30
RS51888B (en)	2012-02-29
US20050159450A1 (en)	2005-07-21
HRP20040977A2 (en)	2004-12-31
UA78025C2 (en)	2007-02-15
NZ536015A (en)	2006-11-30
AU2003262420A1 (en)	2003-11-03
IS2540B (is)	2009-09-15
EA007225B1 (ru)	2006-08-25
MXPA04010326A (es)	2005-07-05
SI1499589T1 (sl)	2007-10-31
CN1662497A (zh)	2005-08-31
ATE361279T1 (de)	2007-05-15

Publication	Publication Date	Title
IL164400A0 (en)	2005-12-18	Deruvatuves if n-Äphenyl(piperidin-2-yl)methylÜbenzamide, the preparation method thereof and application of same in therapeutics
EP1539941A4 (en)	2006-11-29	ADZYMES AND THEIR USES
IL225633A0 (en)	2014-03-31	Antibodies against alpha v beta 6 and uses thereof
PL375691A1 (en)	2005-12-12	Imidazolopyridines and methods of making and using the same
EP1660638A4 (en)	2009-02-18	LIPOPARTICLES COMPRISING PROTEINS, AND METHODS OF MAKING AND USING SAME LIPOPARTICLES
EP1551447A4 (en)	2007-03-07	ANTI-ADDL ANTIBODIES AND USES THEREOF
IL164703A0 (en)	2005-12-18	ImidazoÄ1,2-AÜpyrazin-8-ylamines method of making and method of use thereof
AU2003274211A8 (en)	2004-02-25	Flame-retardant composition, preparation method and use thereof
AU2003239614A8 (en)	2003-12-12	Cardiolipin compositions, methods of preparation and use
AU2003296369A8 (en)	2004-06-30	Imminoamines and preparation thereof
AU2003271183A1 (en)	2004-05-04	Block copolymer and application thereof
AU2002346446A1 (en)	2003-06-10	Methods and compositions in checkpoint signaling
IL166063A0 (en)	2006-01-15	Antibodies and uses thereof
AU2003231827A8 (en)	2003-12-12	Pseudo-tissues and uses thereof
AU2003228355A8 (en)	2003-10-13	Adipocytes and uses thereof
EP1517879A4 (en)	2006-09-13	AMINOALKYLPHENOLS AND METHODS OF USE AND MANUFACTURE
AU2003300396A8 (en)	2004-07-22	Chemokine antagonists and uses thereof
GB0207624D0 (en)	2002-05-15	Chemokine and uses thereof
AU2003300859A8 (en)	2004-06-30	Carrier-ligand fusions and uses thereof
GB0229445D0 (en)	2003-01-22	Process,composition and use
AU2003216442A8 (en)	2003-09-09	Enkurin and uses thereof
GB0203528D0 (en)	2002-04-03	Process and composition
GB0211116D0 (en)	2002-06-26	Composition and method
GB0210747D0 (en)	2002-06-19	Composition and method
GB0210365D0 (en)	2002-06-12	Composition and method